Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for G3X9K3

Entry ID Method Resolution Chain Position Source
AF-G3X9K3-F1 Predicted AlphaFoldDB

77 variants for G3X9K3

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388458389 45 K>I No EVA
rs3388458176 46 V>I No EVA
rs3388458548 148 Q>L No EVA
rs3388456645 263 G>A No EVA
rs3388457730 266 E>K No EVA
rs3388457874 267 P>T No EVA
rs1133297506 311 D>E No EVA
rs1134028249 314 Y>* No EVA
rs1133435516 317 D>N No EVA
rs1134763054 319 E>Q No EVA
rs1134163842 320 E>K No EVA
rs1131761456 320 E>V No EVA
rs3388458554 326 V>I No EVA
rs3388458883 332 E>A No EVA
rs3388458525 415 I>N No EVA
rs3388457759 416 L>F No EVA
rs3388457588 506 L>P No EVA
rs3388458934 519 Q>* No EVA
rs3388457883 538 S>L No EVA
rs3388456628 558 S>* No EVA
rs3388458421 560 V>E No EVA
rs3388456657 560 V>R No EVA
rs3388456625 583 L>P No EVA
rs3388457957 584 S>P No EVA
rs3388457573 604 S>C No EVA
rs3388457959 606 R>* No EVA
rs3388457560 607 K>R No EVA
rs3388457583 701 Q>* No EVA
rs3388458324 723 L>F No EVA
rs3388458532 725 T>S No EVA
rs3388457561 746 G>S No EVA
rs3388456631 748 F>* No EVA
rs3388458545 748 F>L No EVA
rs3388458330 749 L>R No EVA
rs3388457526 786 R>G No EVA
rs3388458339 792 Q>H No EVA
rs3388457909 795 D>E No EVA
rs3388458734 796 R>* No EVA
rs3388458901 804 R>* No EVA
rs3388457569 933 F>Y No EVA
rs3388458924 947 K>* No EVA
rs3388456644 949 A>D No EVA
rs3388458926 1078 T>N No EVA
rs3388458283 1123 D>N No EVA
rs3388457980 1220 E>V No EVA
rs3388457974 1241 M>T No EVA
rs3388456731 1281 L>V No EVA
rs3388457700 1283 A>T No EVA
rs1134759192 1335 D>E No EVA
rs1133706329 1336 T>K No EVA
rs1133170231 1337 S>R No EVA
rs1134350551 1342 R>Q No EVA
rs1131896567 1347 C>Y No EVA
rs3388457371 1357 A>S No EVA
rs3388457613 1359 K>N No EVA
rs3388457841 1375 W>* No EVA
rs3388458897 1396 D>Y No EVA
rs3413024385 1398 R>K No EVA
rs3388456626 1425 F>S No EVA
rs3388457852 1434 N>I No EVA
rs3388457684 1464 T>I No EVA
rs3388458595 1471 S>R No EVA
rs3388458899 1512 F>Y No EVA
rs3388458939 1608 Q>* No EVA
rs3388458935 1617 K>N No EVA
rs3388456563 1639 K>E No EVA
rs3388456590 1642 D>N No EVA
rs3388458671 1651 R>I No EVA
rs3388456558 1667 M>I No EVA
rs3388457584 1671 L>* No EVA
rs3389644154 1682 C>S No EVA
rs3388456584 1691 K>* No EVA
rs3388458311 1696 N>D No EVA
rs47170348 1754 V>I No EVA
rs3388457579 1764 T>I No EVA
rs46017648 1791 S>N No EVA
rs3388458687 1829 I>M No EVA

No associated diseases with G3X9K3

9 regional properties for G3X9K3

Type Name Position InterPro Accession
domain Peptidase C19, ubiquitin carboxyl-terminal hydrolase 326 - 853 IPR001394
domain Zinc finger, UBP-type 175 - 283 IPR001607
domain Ubiquitin-associated domain 654 - 695 IPR015940-1
domain Ubiquitin-associated domain 722 - 762 IPR015940-2
conserved_site Ubiquitin specific protease, conserved site 327 - 342 IPR018200-1
conserved_site Ubiquitin specific protease, conserved site 801 - 819 IPR018200-2
domain Ubiquitin specific protease domain 326 - 856 IPR028889
domain Ubiquitinyl hydrolase, variant UBP zinc finger 16 - 78 IPR041432
domain Ubiquitin carboxyl-terminal hydrolase 5, UBA1 domain 655 - 702 IPR041812

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Cytoplasm, perinuclear region
  • Golgi apparatus
  • Golgi apparatus, trans-Golgi network
  • Nucleus
  • Nucleus, nucleolus
  • Nucleus matrix
  • Membrane
  • Translocates from cytoplasm to membranes and nucleus upon cAMP treatment
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

9 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
Golgi apparatus A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways.
Golgi membrane The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
nuclear matrix The dense fibrillar network lying on the inner side of the nuclear membrane.
nucleolus A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
perinuclear region of cytoplasm Cytoplasm situated near, or occurring around, the nucleus.
small nuclear ribonucleoprotein complex A ribonucleoprotein complex that contains at least one RNA of the small nuclear RNA (snRNA) class and as well as its associated proteins. These are typically named after the snRNA(s) they contain, e.g. U1 snRNP, U4/U6 snRNP, or 7SK snRNP. Many, of these complexes become part of the spliceosome involved in splicing of nuclear mRNAs. Others are involved in regulation of transcription elongation or 3'-end processing of replication-dependent histone pre-mRNAs.
trans-Golgi network The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination.

3 GO annotations of molecular function

Name Definition
guanyl-nucleotide exchange factor activity Stimulates the exchange of GDP to GTP on a signaling GTPase, changing its conformation to its active form. Guanine nucleotide exchange factors (GEFs) act by stimulating the release of guanosine diphosphate (GDP) to allow binding of guanosine triphosphate (GTP), which is more abundant in the cell under normal cellular physiological conditions.
myosin binding Binding to a myosin; myosins are any of a superfamily of molecular motor proteins that bind to actin and use the energy of ATP hydrolysis to generate force and movement along actin filaments.
protein kinase A regulatory subunit binding Binding to one or both of the regulatory subunits of protein kinase A.

11 GO annotations of biological process

Name Definition
endomembrane system organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the endomembrane system.
Golgi organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the Golgi apparatus.
negative regulation of actin filament polymerization Any process that stops, prevents, or reduces the frequency, rate or extent of actin polymerization.
negative regulation of GTPase activity Any process that stops or reduces the rate of GTP hydrolysis by a GTPase.
neuron projection development The process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
positive regulation of protein kinase B signaling Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
positive regulation of wound healing Any process that increases the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury.
protein glycosylation A protein modification process that results in the addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid, e.g. the addition of glycan chains to proteins.
protein transport The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
regulation of ARF protein signal transduction Any process that modulates the frequency, rate or extent of ARF protein signal transduction.
regulation of establishment of cell polarity Any process that modulates the frequency, rate or extent of establishment of cell polarity.

13 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O46382 ARFGEF1 Brefeldin A-inhibited guanine nucleotide-exchange protein 1 Bos taurus (Bovine) PR
Q9Y6D5 ARFGEF2 Brefeldin A-inhibited guanine nucleotide-exchange protein 2 Homo sapiens (Human) PR
Q9Y6D6 ARFGEF1 Brefeldin A-inhibited guanine nucleotide-exchange protein 1 Homo sapiens (Human) PR
A2A5R2 Arfgef2 Brefeldin A-inhibited guanine nucleotide-exchange protein 2 Mus musculus (Mouse) PR
Q3TES0 Iqsec3 IQ motif and SEC7 domain-containing protein 3 Mus musculus (Mouse) SS
Q80YW0 Cyth4 Cytohesin-4 Mus musculus (Mouse) SS
O08967 Cyth3 Cytohesin-3 Mus musculus (Mouse) EV
Q8R0S2 Iqsec1 IQ motif and SEC7 domain-containing protein 1 Mus musculus (Mouse) SS
P63034 Cyth2 Cytohesin-2 Mus musculus (Mouse) SS
Q9QX11 Cyth1 Cytohesin-1 Mus musculus (Mouse) SS
Q5DU25 Iqsec2 IQ motif and SEC7 domain-containing protein 2 Mus musculus (Mouse) SS
D4A631 Arfgef1 Brefeldin A-inhibited guanine nucleotide-exchange protein 1 Rattus norvegicus (Rat) PR
Q7TSU1 Arfgef2 Brefeldin A-inhibited guanine nucleotide-exchange protein 2 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MYEGKKTKNM FLTRALEKIL ADKEVKKAHH SQLRKACEVA LEEIKVETEK QSPPHGEAKA
70 80 90 100 110 120
GSGTLPPVKS KTNFIEADKY FLPFELACQS KCPRIVSTSL DCLQKLIAYG HLTGRAPDST
130 140 150 160 170 180
TPGKKLIDRI IETICGCFQG PQTDEGVQLQ IIKALLTAVT SQHIEIHEGT VLQAVRTCYN
190 200 210 220 230 240
IYLASKNLIN QTTAKATLTQ MLNVIFARME NQALQEAKQM ERERHRQQQH LLQSPVSHHE
250 260 270 280 290 300
PESPHLRYLP PQTVDHINQE HEGDLEPQTH DVDKSLQDDT EPENGSDISS AENEQTEADQ
310 320 330 340 350 360
ATAAETLSKN DILYDGDYEE KPLDIVQSIV EEMVNIIVGD MGEGMAISAS TEGNTGTVED
370 380 390 400 410 420
GSDSENIQAN GIPGTPISVA YTPSLPDDRL SVSSNDTQES GNSSGPSPGA KFSHILQKDA
430 440 450 460 470 480
FLVFRSLCKL SMKPLSDGPP DPKSHELRSK ILSLQLLLSI LQNAGPVFRT NEMFINAIKQ
490 500 510 520 530 540
YLCVALSKNG VSSVPEVFEL SLSIFLTLLS NFKTHLKMQI EVFFKEIFLY ILETSTSSFD
550 560 570 580 590 600
HKWMVIQTLT RICADAQSVV DIYVNYDCDL NAANIFERLV NDLSKIAQGR GSQELGMSNV
610 620 630 640 650 660
QELSLRKKGL ECLVSILKCM VEWSKDQYVN PNSQTTLGQE KPSEQEISEV KHPETINRYG
670 680 690 700 710 720
SLNSLESTSS SGIGSYSTQM SGTDNPEQFE VLKQQKEIIE QGIDLFNKKP KRGIQYLQEQ
730 740 750 760 770 780
GMLGTTPEDI AQFLHQEERL DSTQVGEFLG DNDKFNKEVM YAYVDQHDFS GKDFVSALRL
790 800 810 820 830 840
FLEGFRLPGE AQKIDRLMEK FAARYLECNQ GQTLFASADT AYVLAYSIIM LTTDLHSPQV
850 860 870 880 890 900
KNKMTKEQYI KMNRGINDSK DLPEEYLSAI YNEIAGKKIS MKETKELTIP TKSTKQNVAS
910 920 930 940 950 960
EKQRRLLYNL EMEQMAKTAK ALMEAVSHVQ APFTSATHLE HVRPMFKLAW TPFLAAFSVG
970 980 990 1000 1010 1020
LQDCDDTEVA SLCLEGIRCA IRIACIFSIQ LERDAYVQAL ARFTLLTVSS GITEMKQKNI
1030 1040 1050 1060 1070 1080
DTIKTLITVA HTDGNYLGNS WHEILKCISQ LELAQLIGTG VKPRYISGTV RGREGSLTGT
1090 1100 1110 1120 1130 1140
KDQAPDEFVG LGLVGGNVDW KQIASIQESI GETSSQSVVV AVDRIFTGST RLDGNAIVDF
1150 1160 1170 1180 1190 1200
VRWLCAVSMD ELLSTTHPRM FSLQKIVEIS YYNMGRIRLQ WSRIWEVIGD HFNKVGCNPN
1210 1220 1230 1240 1250 1260
EDVAIFAVDS LRQLSMKFLE KGELANFRFQ KDFLRPFEHI MKRNRSPTIR DMVVRCIAQM
1270 1280 1290 1300 1310 1320
VNSQAANIRS GWKNIFSVFH LAASDQDESI VELAFQTTGH IVTLVFEKHF PATIDSFQDA
1330 1340 1350 1360 1370 1380
VKCLSEFACN AAFPDTSMEA IRLIRHCAKY VSDRPQAFKE YTSDDMSVAP EDRVWVRGWF
1390 1400 1410 1420 1430 1440
PILFELSCII NRCKLDVRTR GLTVMFEIMK TYGHTYEKHW WQDLFRIVFR IFDNMKLPEQ
1450 1460 1470 1480 1490 1500
QTEKAEWMTT TCNHALYAIC DVFTQYLEVL SDVLLDDIFA QLYWCVQQDN EQLARSGTNC
1510 1520 1530 1540 1550 1560
LENVVILNGE KFTLEIWDKT CNCTLDIFKT TIPHALLTWR PTSGEAEPPS PSAVSEKPLD
1570 1580 1590 1600 1610 1620
AISQKSVDIH DSIQPRSSDN RQQAPLVSVS TVSEEVSKVK STAKFPEQKL FAALLIKCVV
1630 1640 1650 1660 1670 1680
QLELIQTIDN IVFFPATSKK EDAENLAAAQ RDAVDFDVRV DTQDQGMYRF LTSQQLFKLL
1690 1700 1710 1720 1730 1740
DCLLESHRFA KAFNSNNEQR TALWKAGFKG KSKPNLLKQE TSSLACGLRI LFRMYMDESR
1750 1760 1770 1780 1790 1800
VSAWEEVQQR LLNVCREALS YFLTLTSESH REAWTNLLLL FLTKVLKISD SRFKAHASFY
1810 1820 1830 1840
YPLLCEIMQF DLIPELRAVL RRFFLRIGIV FQISQPPEQE LGINRQ